Who owns ENTRADA THERAPEUTICS INC?
- Ticker: TRDA
- CUSIP Number: 29384c108
Tip: Access positions for across all investors
Analyze quarterly positions in Entrada Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Entrada Therapeutics stock
Who bought or sold ENTRADA THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Baker Bros. Advisors | 4.9M | $78M | 0% | Sep 2024 |
|
MPM Asset Management | 4.4M | $63M | 0% | Jun 2024 |
|
5AM Venture Management | 4.4M | $70M | 0% | Sep 2024 |
|
T. Rowe Price Associates | 3.0M | $49M | -3% | Sep 2024 |
|
BlackRock | 1.8M | $29M | 100% | Sep 2024 |
|
BlackRock | 1.7M | $24M | 14% | Jun 2024 |
|
Henderson Group | 1.5M | $22M | 100% | Jun 2024 |
|
Vanguard Group | 1.1M | $16M | 5% | Jun 2024 |
|
StepStone | 761k | $12M | 0% | Sep 2024 |
|
TCG Crossover Management | 585k | $8.3M | 0% | Jun 2024 |
|
Geode Capital Management | 577k | $9.2M | 9% | Sep 2024 |
|
State Street Corporation | 445k | $6.3M | 2% | Jun 2024 |
|
Northern Trust | 248k | $4.0M | 24% | Sep 2024 |
|
Jacobs Levy Equity Management | 202k | $3.2M | 50% | Sep 2024 |
|
Charles Schwab Investment Management | 186k | $3.0M | 15% | Sep 2024 |
|
Connor, Clark & Lunn Investment Management | 139k | $2.2M | 132% | Sep 2024 |
|
Nuveen Asset Management | 123k | $1.8M | 115% | Jun 2024 |
|
Moore Capital Management | 105k | $1.5M | 0% | Jun 2024 |
|
Bank of New York Mellon | 105k | $1.7M | -16% | Sep 2024 |
|
Marshall Wace | 100k | $1.6M | 52% | Sep 2024 |
|
Arrowstreet Capital, Limited Partnership | 100k | $1.6M | 597% | Sep 2024 |
|
Citadel Advisors | 98k | $1.6M | -25% | Sep 2024 |
|
Dimensional Fund Advisors | 95k | $1.5M | 100% | Sep 2024 |
|
Renaissance Technologies | 94k | $1.5M | 110% | Sep 2024 |
|
First Trust Advisors | 82k | $1.3M | 100% | Sep 2024 |
|
Massachusetts Financial Services | 69k | $1.1M | 100% | Sep 2024 |
|
Acadian Asset Management | 66k | $1.0M | 390% | Sep 2024 |
|
Corton Capital | 58k | $924k | 5% | Sep 2024 |
|
Deerfield Management Company | 57k | $916k | 100% | Sep 2024 |
|
Manufacturers Life Insurance Company | 57k | $814k | 4% | Jun 2024 |
|
American Century Companies | 51k | $811k | -87% | Sep 2024 |
|
Nan Fung Group Holdings | 49k | $784k | 0% | Sep 2024 |
|
Morgan Stanley | 49k | $699k | -54% | Jun 2024 |
|
LPL Financial | 49k | $781k | 100% | Sep 2024 |
|
TD Asset Management | 48k | $786k | -33% | Sep 2024 |
|
Barclays | 45k | $720k | 211% | Sep 2024 |
|
Susquehanna International | 41k | $655k | 100% | Sep 2024 |
|
AQR Capital Management | 40k | $632k | 100% | Sep 2024 |
|
Lazard Asset Management | 39k | $630k | 1180% | Sep 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 39k | $615k | 35% | Sep 2024 |
|
GSA Capital Partners | 37k | $585k | 72% | Sep 2024 |
|
Rhumbline Advisers | 36k | $580k | -2% | Sep 2024 |
|
Bank of America Corporation | 34k | $544k | 18% | Sep 2024 |
|
Thomas Stevens, CFA" | 34k | $542k | 100% | Sep 2024 |
|
Goldman Sachs Group | 33k | $475k | 92% | Jun 2024 |
|
Swiss National Bank | 33k | $524k | 0% | Sep 2024 |
|
Martingale Asset Management | 28k | $395k | 50% | Jun 2024 |
|
Squarepoint Ops | 26k | $370k | -24% | Jun 2024 |
|
WCG Wealth Advisors | 23k | $362k | 100% | Sep 2024 |
|
Allspring Global Investments Holdings | 21k | $328k | -26% | Sep 2024 |
|
Citigroup | 18k | $288k | 224% | Sep 2024 |
|
California State Teachers Retirement System | 16k | $261k | -3% | Sep 2024 |
|
Franklin Resources | 16k | $291k | 0% | Sep 2024 |
|
Ohio Pers | 16k | $260k | 89% | Sep 2024 |
|
Trexquant Investment | 16k | $251k | 100% | Sep 2024 |
|
Jane Street | 16k | $248k | -42% | Sep 2024 |
|
ExodusPoint Capital Management | 15k | $245k | 100% | Sep 2024 |
|
Royal Bank of Canada | 15k | $248k | 80% | Sep 2024 |
|
Florida State Board of Administration | 15k | $236k | 100% | Sep 2024 |
|
MetLife Investment Advisors | 15k | $233k | 0% | Sep 2024 |
|
Deutsche Bank Aktiengesellschaft | 14k | $223k | 37% | Sep 2024 |
|
Mirae Asset Global Etfs Holdings | 14k | $217k | 19% | Sep 2024 |
|
EntryPoint Capital | 13k | $206k | 100% | Sep 2024 |
|
PDT Partners | 13k | $202k | 1% | Sep 2024 |
|
Cornerstone Investment Partners | 12k | $190k | 4% | Sep 2024 |
|
Sherbrooke Park Advisers | 12k | $185k | 100% | Sep 2024 |
|
Wells Fargo & Company | 11k | $182k | 4% | Sep 2024 |
|
Jpmorgan Chase & Co | 11k | $173k | 2% | Sep 2024 |
|
Alliancebernstein | 10k | $146k | 100% | Jun 2024 |
|
SG Americas Securities | 9.7k | $156k | 100% | Sep 2024 |
|
New York State Common Retirement Fund | 8.9k | $142k | 0% | Sep 2024 |
|
Federated Investors | 3.1k | $50k | 228% | Sep 2024 |
|
Tower Research Capital | 2.9k | $41k | 562% | Jun 2024 |
|
Us Bancorp | 2.7k | $43k | 100% | Sep 2024 |
|
Summit Investment Advisors | 2.4k | $39k | 37% | Sep 2024 |
|
Russell Investments | 2.1k | $29k | 22789% | Jun 2024 |
|
Simplex Trading | 1.0k | $16k | 100% | Sep 2024 |
|
Amalgamated Bank | 721.00 | $12k | 0% | Sep 2024 |
|
Advisor Group Holdings | 377.00 | $6.0k | 100% | Sep 2024 |
|
CWM | 150.00 | $2.0k | 782% | Sep 2024 |
|
Smartleaf Asset Management | 133.00 | $2.2k | 100% | Sep 2024 |
|
Sterling Capital Management | 90.00 | $1.4k | 100% | Sep 2024 |
|
Capital Performance Advisors | 71.00 | $1.1k | 100% | Sep 2024 |
|
SRS Capital Advisors | 45.00 | $720.000000 | 0% | Sep 2024 |
|
GAMMA Investing | 40.00 | $639.000000 | 0% | Sep 2024 |
|
C.M. Bidwell & Associates | 29.00 | $462.999500 | 100% | Sep 2024 |
|
NISA Investment Advisors | 21.00 | $336.000000 | -64% | Sep 2024 |
|
Who sold out of Entrada Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Redmile Group | Jun 2024 | 561k | $8.0M |
Millennium Management | Jun 2024 | 147k | $2.1M |
Schonfeld Strategic Advisors | Jun 2024 | 81k | $1.2M |
Invesco | Jun 2024 | 46k | $648k |
Man Group | Jun 2024 | 17k | $246k |
CornerCap Investment Counsel | Jun 2024 | 13k | $185k |
Plato Investment Management | Jun 2024 | 61.00 | $868.999900 |